Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 11 |
GO:0030014 | CCR4-NOT complex | 3 | 11 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0140535 | intracellular protein-containing complex | 2 | 12 |
GO:0000932 | P-body | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0010494 | cytoplasmic stress granule | 5 | 1 |
GO:0030015 | CCR4-NOT core complex | 3 | 1 |
GO:0035770 | ribonucleoprotein granule | 3 | 1 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
Related structures:
AlphaFold database: A4I022
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006401 | RNA catabolic process | 5 | 12 |
GO:0006402 | mRNA catabolic process | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009056 | catabolic process | 2 | 12 |
GO:0009057 | macromolecule catabolic process | 4 | 12 |
GO:0009892 | negative regulation of metabolic process | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0010468 | regulation of gene expression | 5 | 12 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 12 |
GO:0010629 | negative regulation of gene expression | 6 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0019222 | regulation of metabolic process | 3 | 12 |
GO:0019439 | aromatic compound catabolic process | 4 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044248 | cellular catabolic process | 3 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 12 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0046700 | heterocycle catabolic process | 4 | 12 |
GO:0048519 | negative regulation of biological process | 3 | 12 |
GO:0050789 | regulation of biological process | 2 | 12 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 12 |
GO:0065007 | biological regulation | 1 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 12 |
GO:1901575 | organic substance catabolic process | 3 | 12 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 8 | 1 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7 | 1 |
GO:0043928 | exonucleolytic catabolism of deadenylated mRNA | 9 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 12 |
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004518 | nuclease activity | 4 | 12 |
GO:0004527 | exonuclease activity | 5 | 12 |
GO:0004532 | RNA exonuclease activity | 5 | 12 |
GO:0004535 | poly(A)-specific ribonuclease activity | 8 | 12 |
GO:0004540 | RNA nuclease activity | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 12 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003727 | single-stranded RNA binding | 5 | 1 |
GO:0008143 | poly(A) binding | 7 | 1 |
GO:0070717 | poly-purine tract binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 242 | 244 | PF00675 | 0.244 |
CLV_NRD_NRD_1 | 336 | 338 | PF00675 | 0.732 |
CLV_PCSK_KEX2_1 | 242 | 244 | PF00082 | 0.244 |
CLV_PCSK_KEX2_1 | 336 | 338 | PF00082 | 0.732 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.241 |
CLV_Separin_Metazoa | 136 | 140 | PF03568 | 0.530 |
DOC_MAPK_MEF2A_6 | 54 | 61 | PF00069 | 0.462 |
DOC_MAPK_MEF2A_6 | 95 | 103 | PF00069 | 0.444 |
DOC_PP1_RVXF_1 | 172 | 179 | PF00149 | 0.297 |
DOC_PP4_FxxP_1 | 310 | 313 | PF00568 | 0.689 |
DOC_SPAK_OSR1_1 | 122 | 126 | PF12202 | 0.549 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.444 |
DOC_USP7_MATH_1 | 288 | 292 | PF00917 | 0.556 |
DOC_USP7_MATH_1 | 330 | 334 | PF00917 | 0.683 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.464 |
DOC_USP7_MATH_1 | 72 | 76 | PF00917 | 0.486 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.604 |
DOC_WW_Pin1_4 | 290 | 295 | PF00397 | 0.510 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.693 |
DOC_WW_Pin1_4 | 309 | 314 | PF00397 | 0.399 |
LIG_14-3-3_CanoR_1 | 222 | 230 | PF00244 | 0.456 |
LIG_14-3-3_CterR_2 | 336 | 338 | PF00244 | 0.596 |
LIG_BRCT_BRCA1_1 | 226 | 230 | PF00533 | 0.530 |
LIG_BRCT_BRCA1_1 | 306 | 310 | PF00533 | 0.700 |
LIG_BRCT_BRCA1_1 | 322 | 326 | PF00533 | 0.390 |
LIG_eIF4E_1 | 182 | 188 | PF01652 | 0.456 |
LIG_FHA_1 | 270 | 276 | PF00498 | 0.511 |
LIG_FHA_2 | 76 | 82 | PF00498 | 0.505 |
LIG_IRF3_LxIS_1 | 158 | 164 | PF10401 | 0.337 |
LIG_LIR_Apic_2 | 307 | 313 | PF02991 | 0.687 |
LIG_LIR_Gen_1 | 146 | 155 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 156 | 163 | PF02991 | 0.327 |
LIG_LIR_Gen_1 | 43 | 53 | PF02991 | 0.453 |
LIG_LIR_Gen_1 | 55 | 66 | PF02991 | 0.419 |
LIG_LIR_Gen_1 | 81 | 91 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 146 | 151 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 156 | 161 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 183 | 187 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 43 | 49 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 62 | 68 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 81 | 87 | PF02991 | 0.444 |
LIG_LYPXL_yS_3 | 56 | 59 | PF13949 | 0.436 |
LIG_MAD2 | 189 | 197 | PF02301 | 0.456 |
LIG_NRBOX | 216 | 222 | PF00104 | 0.530 |
LIG_Pex14_1 | 117 | 121 | PF04695 | 0.444 |
LIG_Pex14_2 | 119 | 123 | PF04695 | 0.444 |
LIG_Pex14_2 | 211 | 215 | PF04695 | 0.475 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.444 |
LIG_SH2_GRB2like | 147 | 150 | PF00017 | 0.530 |
LIG_SH2_STAP1 | 10 | 14 | PF00017 | 0.733 |
LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.659 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.338 |
LIG_SH3_3 | 324 | 330 | PF00018 | 0.587 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.442 |
LIG_SUMO_SIM_anti_2 | 133 | 139 | PF11976 | 0.505 |
LIG_UBA3_1 | 210 | 218 | PF00899 | 0.530 |
LIG_WRC_WIRS_1 | 73 | 78 | PF05994 | 0.505 |
MOD_CK1_1 | 254 | 260 | PF00069 | 0.316 |
MOD_CK1_1 | 290 | 296 | PF00069 | 0.524 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.692 |
MOD_CK1_1 | 322 | 328 | PF00069 | 0.646 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.466 |
MOD_CK1_1 | 75 | 81 | PF00069 | 0.465 |
MOD_CK2_1 | 121 | 127 | PF00069 | 0.505 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.485 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.334 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.572 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.567 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.634 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.512 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.495 |
MOD_GSK3_1 | 288 | 295 | PF00069 | 0.550 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.602 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.496 |
MOD_N-GLC_1 | 308 | 313 | PF02516 | 0.647 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.505 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.336 |
MOD_NEK2_1 | 203 | 208 | PF00069 | 0.505 |
MOD_NEK2_1 | 235 | 240 | PF00069 | 0.453 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.486 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.448 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.442 |
MOD_NEK2_2 | 72 | 77 | PF00069 | 0.472 |
MOD_NEK2_2 | 83 | 88 | PF00069 | 0.408 |
MOD_PIKK_1 | 298 | 304 | PF00454 | 0.664 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.505 |
MOD_PKA_2 | 221 | 227 | PF00069 | 0.444 |
MOD_PKA_2 | 265 | 271 | PF00069 | 0.457 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.483 |
MOD_Plk_4 | 210 | 216 | PF00069 | 0.463 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.317 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.602 |
MOD_ProDKin_1 | 290 | 296 | PF00069 | 0.507 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.694 |
MOD_ProDKin_1 | 309 | 315 | PF00069 | 0.396 |
MOD_SUMO_rev_2 | 213 | 220 | PF00179 | 0.505 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.338 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.437 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.444 |
TRG_ER_diArg_1 | 241 | 243 | PF00400 | 0.450 |
TRG_ER_diArg_1 | 335 | 337 | PF00400 | 0.704 |
TRG_Pf-PMV_PEXEL_1 | 194 | 198 | PF00026 | 0.256 |
TRG_Pf-PMV_PEXEL_1 | 50 | 55 | PF00026 | 0.256 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4Q3 | Leptomonas seymouri | 84% | 100% |
A0A0S4J507 | Bodo saltans | 72% | 98% |
A0A1X0NTJ0 | Trypanosomatidae | 72% | 100% |
A0A3Q8IBK8 | Leishmania donovani | 100% | 100% |
A0A422N5D9 | Trypanosoma rangeli | 71% | 100% |
A4HCK3 | Leishmania braziliensis | 94% | 100% |
A4II96 | Xenopus tropicalis | 52% | 100% |
C9ZQ67 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 96% |
E9AVZ5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
O64773 | Arabidopsis thaliana | 33% | 100% |
O74856 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 48% | 100% |
P39008 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 38% | 78% |
Q08BM8 | Danio rerio | 51% | 100% |
Q17345 | Caenorhabditis elegans | 46% | 100% |
Q3KQ85 | Xenopus laevis | 51% | 100% |
Q3ZC01 | Bos taurus | 52% | 100% |
Q4QBI4 | Leishmania major | 99% | 100% |
Q5ZJV9 | Gallus gallus | 52% | 100% |
Q60809 | Mus musculus | 52% | 100% |
Q9C6M9 | Arabidopsis thaliana | 32% | 100% |
Q9D8X5 | Mus musculus | 49% | 100% |
Q9FMS6 | Arabidopsis thaliana | 43% | 100% |
Q9LEU4 | Arabidopsis thaliana | 47% | 100% |
Q9LXM2 | Arabidopsis thaliana | 42% | 100% |
Q9S9P2 | Arabidopsis thaliana | 43% | 100% |
Q9SAI2 | Arabidopsis thaliana | 48% | 100% |
Q9SFX6 | Arabidopsis thaliana | 33% | 100% |
Q9SHJ0 | Arabidopsis thaliana | 32% | 94% |
Q9SKZ2 | Arabidopsis thaliana | 51% | 100% |
Q9UFF9 | Homo sapiens | 49% | 100% |
Q9UIV1 | Homo sapiens | 52% | 100% |
V5B7G1 | Trypanosoma cruzi | 74% | 100% |